358 related articles for article (PubMed ID: 26388396)
1. Mitochondrial dynamics and quality control in Huntington's disease.
Guedes-Dias P; Pinho BR; Soares TR; de Proença J; Duchen MR; Oliveira JM
Neurobiol Dis; 2016 Jun; 90():51-7. PubMed ID: 26388396
[TBL] [Abstract][Full Text] [Related]
2. Targeting the proteostasis network in Huntington's disease.
Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.
Sawant N; Morton H; Kshirsagar S; Reddy AP; Reddy PH
Mol Neurobiol; 2021 Dec; 58(12):6350-6377. PubMed ID: 34519969
[TBL] [Abstract][Full Text] [Related]
4. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
Oliveira JM
J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
[TBL] [Abstract][Full Text] [Related]
5. Huntington's Disease and Mitochondria.
Jodeiri Farshbaf M; Ghaedi K
Neurotox Res; 2017 Oct; 32(3):518-529. PubMed ID: 28639241
[TBL] [Abstract][Full Text] [Related]
6. PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.
Khalil B; El Fissi N; Aouane A; Cabirol-Pol MJ; Rival T; Liévens JC
Cell Death Dis; 2015 Jan; 6(1):e1617. PubMed ID: 25611391
[TBL] [Abstract][Full Text] [Related]
7. Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.
Yablonska S; Ganesan V; Ferrando LM; Kim J; Pyzel A; Baranova OV; Khattar NK; Larkin TM; Baranov SV; Chen N; Strohlein CE; Stevens DA; Wang X; Chang YF; Schurdak ME; Carlisle DL; Minden JS; Friedlander RM
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16593-16602. PubMed ID: 31346086
[TBL] [Abstract][Full Text] [Related]
8. Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
Reddy PH
Drug Discov Today; 2014 Jul; 19(7):951-5. PubMed ID: 24681059
[TBL] [Abstract][Full Text] [Related]
9. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E
Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495
[TBL] [Abstract][Full Text] [Related]
10. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca
Cherubini M; Lopez-Molina L; Gines S
Neurobiol Dis; 2020 Mar; 136():104741. PubMed ID: 31931142
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.
Cherubini M; Ginés S
Biochem Biophys Res Commun; 2017 Feb; 483(4):1063-1068. PubMed ID: 27514446
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations.
Neueder A; Kojer K; Gu Z; Wang Y; Hering T; Tabrizi S; Taanman JW; Orth M
Brain; 2024 Jun; 147(6):2009-2022. PubMed ID: 38195181
[TBL] [Abstract][Full Text] [Related]
14. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
15. Defective Mitochondrial Dynamics and Protein Degradation Pathways Underlie Cadmium-Induced Neurotoxicity and Cell Death in Huntington's Disease Striatal Cells.
Kamitsuka PJ; Ghanem MM; Ziar R; McDonald SE; Thomas MG; Kwakye GF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108341
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration.
Oliveira JM
J Bioenerg Biomembr; 2010 Jun; 42(3):227-34. PubMed ID: 20454921
[TBL] [Abstract][Full Text] [Related]
17. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
[TBL] [Abstract][Full Text] [Related]
18. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
Faideau M; Kim J; Cormier K; Gilmore R; Welch M; Auregan G; Dufour N; Guillermier M; Brouillet E; Hantraye P; Déglon N; Ferrante RJ; Bonvento G
Hum Mol Genet; 2010 Aug; 19(15):3053-67. PubMed ID: 20494921
[TBL] [Abstract][Full Text] [Related]
19. Morphological control of mitochondria as the novel mechanism of Gastrodia elata in attenuating mutant huntingtin-induced protein aggregations.
Huang NK; Lin CC; Lin YL; Huang CL; Chiou CT; Lee YC; Lee SY; Huang HT; Yang YC
Phytomedicine; 2019 Jun; 59():152756. PubMed ID: 31004885
[TBL] [Abstract][Full Text] [Related]
20. HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons.
Guedes-Dias P; de Proença J; Soares TR; Leitão-Rocha A; Pinho BR; Duchen MR; Oliveira JM
Biochim Biophys Acta; 2015 Nov; 1852(11):2484-93. PubMed ID: 26300485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
